CN101889976A - Acyclovir injection and preparation method thereof - Google Patents

Acyclovir injection and preparation method thereof Download PDF

Info

Publication number
CN101889976A
CN101889976A CN2009100156235A CN200910015623A CN101889976A CN 101889976 A CN101889976 A CN 101889976A CN 2009100156235 A CN2009100156235 A CN 2009100156235A CN 200910015623 A CN200910015623 A CN 200910015623A CN 101889976 A CN101889976 A CN 101889976A
Authority
CN
China
Prior art keywords
acyclovir
injection
water
preparation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009100156235A
Other languages
Chinese (zh)
Inventor
吴双俊
范兴山
王飞龙
孟爱红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG FANGMING PHARMACEUTICAL CO Ltd
Original Assignee
SHANDONG FANGMING PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG FANGMING PHARMACEUTICAL CO Ltd filed Critical SHANDONG FANGMING PHARMACEUTICAL CO Ltd
Priority to CN2009100156235A priority Critical patent/CN101889976A/en
Publication of CN101889976A publication Critical patent/CN101889976A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to acyclovir injection which is a medical preparation of compounds and a preparation method thereof. The preparation contains acyclovir, sodium hydroxide and water for injection. The method comprises the following steps of: weighing a proper quantity of water for injection and acyclovir; adding acyclovir into water; stirring, and adding sodium hydroxide solution until the pH value of the solution is 11.0-12.0; keeping stirring until acyclovir is completely dissolved; adding activated carbon for needles, stirring for 30 minutes, stirring, adding water to full dose, filtering, encapsulating, sterilizing, lamp inspection and packing to obtain the product, wherein the volume of the carbon for needles is 0.05 percent (g/ml) of the total volume of the solution. The invention has the characteristics of simple prescription and technology, high production efficiency, strong liquid medicine stability and the like.

Description

Acyclovir injection and preparation method thereof
Technical field:
The present invention relates to a kind ofly, be used for the treatment of injection of herpes simplex infections, herpes zoster, immunodeficiency person's chickenpox, acute retinal necrosis etc. and preparation method thereof, belong to field of pharmaceutical technology about containing acyclovir.
Background of invention:
Acyclovir (Acyclovir) is the synthetic class new antiviral drug of anti-biological nucleic acid, has advantages such as high selectivity, spectrum, efficient, low toxicity.
Aspect patent application, the Chinese invention patent ublic specification of application discloses name and has been called the solubilization method (application number 200510122706.6) of acyclovir in injection, wherein relate to organic solvent and surfactant, increased medical-risk virtually, for this reason, we make every effort to find the simplest a kind of method for preparing Acyclovir injection.
Summary of the invention:
The object of the present invention is to provide a kind of is a kind of injection of making of principal agent and preparation method thereof with the acyclovir.
A kind of Acyclovir injection is characterized in that adding in the principal agent acyclovir injection that an amount of PH regulator is made.
The preparation method of described Acyclovir injection is characterised in that gets 1000g water for injection and 25g acyclovir, acyclovir is joined in the water for injection, stirring down, dropping sodium solution to solution pH value is 11.0~12.0, continuing to be stirred to acyclovir dissolves fully, add the needle-use activated carbon of overall solution volume 0.05% (g/ml), stirred 30 minutes, filter, add water to full dose, filtration, embedding, sterilization, lamp inspection, packing are promptly.
The present invention has characteristics such as prescription, technology is simple, production efficiency is high, liquid medicine stability is strong.
The specific embodiment:
The present invention will be described in detail below in conjunction with example:
Acyclovir injection of the present invention and preparation method thereof is characterized in that acyclovir joins in the water for injection, regulates pH value with sodium hydroxide solution, makes stable acyclovir solution, sterilize after the packing aqueous injection.
Embodiment: in the toilet, getting proper amount of water for injection adds in the container, add the 25g acyclovir, stir, stirring down, dropping sodium solution to solution pH value is 11.0~12.0, continuing to be stirred to acyclovir dissolves fully, add the 0.5g active carbon, placed 30 minutes, filter, add water to 1000ml, filtration, embedding, sterilization, lamp inspection, packing are promptly.

Claims (4)

1. Acyclovir injection is characterized in that its liquid infusion preparation by the preparation of 9-(2-ethoxy methyl) guanine.
2. Acyclovir injection according to claim 1, wherein said liquid infusion preparation is an aqueous solution injection.
3. the preparation method of an Acyclovir injection is characterized in that preparing as follows
Get an amount of acyclovir and water for injection by following proportioning:
Acyclovir 25g water for injection 1000g
Get an amount of water for injection and acyclovir by said ratio, acyclovir is joined in the water for injection, stirring down, dropping sodium solution to solution pH value is 11.0~12.0, continuing to be stirred to acyclovir dissolves fully, add the needle-use activated carbon of overall solution volume 0.05% (g/ml), stirred 30 minutes, filter, add to the full amount of water for injection, filtration, embedding, sterilization are promptly.
4. the employed sodium hydroxide of Acyclovir injection according to claim 3 is commercially available medicinal specification.
CN2009100156235A 2009-05-22 2009-05-22 Acyclovir injection and preparation method thereof Pending CN101889976A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100156235A CN101889976A (en) 2009-05-22 2009-05-22 Acyclovir injection and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100156235A CN101889976A (en) 2009-05-22 2009-05-22 Acyclovir injection and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101889976A true CN101889976A (en) 2010-11-24

Family

ID=43099438

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100156235A Pending CN101889976A (en) 2009-05-22 2009-05-22 Acyclovir injection and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101889976A (en)

Similar Documents

Publication Publication Date Title
CN101810569B (en) Enrofloxacin injection liquid and preparation method thereof
CN101455631B (en) Meglumine cyclic adenosine injection and preparation technique thereof
CN102335123A (en) Noradrenaline bitartrate injection and preparation technology thereof
CN1775214A (en) Rifapentine, refampicin, rifabutin or rifamdin injection and its preparing method
CN102335125A (en) Adrenaline hydrochloride injection and preparation process thereof
CN105193803A (en) Ilepcimide sustained release preparation and preparation method thereof
CN102836123A (en) Injection containing levetiracetam active ingredient and technology for preparing injection
RU2012104639A (en) METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF POST-PRANDRANDIAL HYPERGLYCEMIA TYPE II DIABETES BY INTRODUCTION THROUGH THE MURAL ORAL CAVITY
CN102670489A (en) Ropivacaine hydrochloride sodium chloride injection and preparation method thereof
CN102652744B (en) Modified injection containing 13 compound vitamins and preparation method thereof
CN101889976A (en) Acyclovir injection and preparation method thereof
CN103340853B (en) Compound 18-amino acid injection containing little amount of antioxidant and preparation method thereof
CN101455635A (en) Cromoglyn sodium eye drops without bacteria inhibitor and preparation method thereof
CN103027894A (en) Ceftazidime composition for injection and preparation method for ceftazidime composition
CN102525893A (en) Phenylephrine hydrochloride injection and preparation process thereof
CN1151782C (en) Parenteral solution of propofol (2,6-diisopropylphenol) and 2,5-di-O-methyl-1,4,3,6-dianhydro-D-glucitol as solvent
CN101347406A (en) Injection with high-content praziquantel and method of preparing the same
CN103222950B (en) Modified amylase-based nanometer helical oil phase-triggered quick-release material and preparation method thereof
CN102008461B (en) A kind of ibuprofen drug composite for injection
CN102335129B (en) Edaravone medicinal composition for injection and preparation method thereof
CN100509787C (en) New pharmaceutically acceptable salt of pyritinol, and a preparation method thereof
CN101829063B (en) Lung targeting microsphere of veterinary ceftiofur hydrochloride and preparation method
CN102525894A (en) Isoproterenol hydrochloride injection and preparation process thereof
CN102335126A (en) Ornidazole injection and its preparation method
CN102727429B (en) Pidotimod injection with modified stability, and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20101124